Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says
NCI, Dialogue Plan A National Tissue Bank
Group Chairmen Criticize NCI Budget Priorities
Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials
Kimes, Lenfant, To Retire
Cancer.gov Knocked Offline By Theft Of Routers
Six Centers Win Grants
PHS Plans Revitalization of Commissioned Corps
Funding Opportunities Listed (12-page issue).
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A new diagnostic lens—and a lasting scientific legacy
- OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill









